Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Haltbarkeit
6 months
Pan, Wang, Zhu, Xing, Cui, Li, Yu, Wang, Zhu, Ye, Wu, Wang, Lu: "STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer." in: Molecular cancer, Vol. 15, Issue 1, pp. 79, (2017) (PubMed).
Lin, Zheng, Tu, Wang, Liu, Lu, Xu, Yuan: "MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2." in: Human pathology, Vol. 46, Issue 7, pp. 971-80, (2015) (PubMed).
Eskander, Ji, Huynh, Wardeh, Randall, Hoang: "Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines." in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 23, Issue 6, pp. 997-1005, (2014) (PubMed).
Zhou, Flesken-Nikitin, Corney, Wang, Goodrich, Roy-Burman, Nikitin: "Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer." in: Cancer research, Vol. 66, Issue 16, pp. 7889-98, (2007) (PubMed).
EZH2, SUZ12, and EED form a complex that methylates nucleosomal histone H3 at Lys27. EZH2 contains a SET domain, a signature motif for all known histone lysine methyltransferases except the H3-K79 methyltransferase DOT1, and is therefore likely to be the catalytic subunit. Consequently, EZH2 is thought to regulate gene expression by controlling chromatin structure. Several lines of evidence suggested a critical role for the EZH2 protein during normal and perturbed development of the hematopoietic and central nervous systems. The EZH2 protein has been shown to associate with the VAV1 protooncoprotein and with the XNP protein, the product of a gene associated with mental retardation. Additionally, due to mapping of EZH2 to the 7q35-q36 chromosomal region associated with myeloid disorders, this protein is suggested to participate in the genetic events triggering myeloid leukemia.